- REGN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $317.5 million.
- REGN traded 19,250 shares today in the pre-market hours as of 8:12 AM.
- REGN is down 7.1% today from Friday's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in REGN with the Ticky from Trade-Ideas. See the FREE profile for REGN NOW at Trade-Ideas More details on REGN: Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. REGN has a PE ratio of 111.6. Currently there are 10 analysts that rate Regeneron Pharmaceuticals a buy, no analysts rate it a sell, and 5 rate it a hold. The average volume for Regeneron Pharmaceuticals has been 782,500 shares per day over the past 30 days. Regeneron has a market cap of $38.9 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.85 and a short float of 4.9% with 4.35 days to cover. Shares are up 43% year-to-date as of the close of trading on Friday.